Cancer Communications

Articles

Content type: Original article
| 13 August 2018

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4

Authors: Liru He, Haixia Deng, Shiliang Liu, Jiewei Chen, Binkui Li, Chenyuan Wang, Xin Wang, Yiguo Jiang, Ningfang Ma, Mengzhong Liu and Dan Xie
Content type: Editorial
| 3 August 2018

Tumor vasculature: a sally port for inhibiting cancer cell spreading

Authors: Chao-Nan Qian and Francesco Pezzella
Content type: Original article
| 28 July 2018

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience

Authors: Xiangyang Yu, Xuewen Zhang, Zichen Zhang, Yongbin Lin, Yingsheng Wen, Yongqiang Chen, Weidong Wang and Lanjun Zhang
Content type: Original article
| 27 July 2018

Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways

Authors: Yanjun Huang, Sichun Zhou, Caimei He, Jun Deng, Ting Tao, Qiongli Su, Kwame Oteng Darko, Mei Peng and Xiaoping Yang
Content type: Original article
| 25 July 2018

Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining

Authors: Minjie Zhang, Liu Wang, Ke An, Jun Cai, Guochao Li, Caiyun Yang, Huixian Liu, Fengxia Du, Xiao Han, Zilong Zhang, Zitong Zhao, Duanqing Pei, Yuan Long, Xin Xie, Qi Zhou and Yingli Sun

Most recent articles RSS

View all articles

Content type: Review
| 2 July 2015

Predictive biomarkers in precision medicine and drug development against lung cancer

Authors: Bingliang Fang, Reza J Mehran, John V Heymach and Stephen G Swisher
Content type: Original article
| 10 August 2015

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Authors: Xue-Yan Zhang, Ge Zhang, Ying Jiang, Dan Liu, Man-Zhi Li, Qian Zhong, Shan-Qi Zeng, Wan-Li Liu and Mu-Sheng Zeng
Content type: Original article
| 12 August 2015

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Authors: Lu-Jun Shen, Si-Yang Wang, Guo-Feng Xie, Qi Zeng, Chen Chen, An-Nan Dong, Zhi-Mei Huang, Chang-Chuan Pan, Yun-Fei Xia and Pei-Hong Wu
Content type: Original article
| 15 August 2015

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Authors: Huixin Ming, Ying Lan, Feng He, Xue Xiao, Xiaoying Zhou, Zhe Zhang, Ping Li and Guangwu Huang
Content type: Review
| 7 April 2016

Cell-free circulating tumor DNA in cancer

Authors: Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang

Most accessed articles RSS

View all articles

2018

Thematic series
Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

2017

Thematic series
Tumor Metastasis
Edited by Jian Zhang and Chao-Nan Qian

2016

Thematic series
Gastric Cancer
Edited by Yun Dai and Li Yan

Thematic series
Tumor Angiogenesis
Edited by Francesco Pezzella and Chao-Nan Qian

2015

Thematic series
Lung Cancer
Edited by Lin Yan and Wei Zhang

Archival content

To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.

Important notice

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1^st March 2018.

Thematic series

Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

Tumor metastasis
Edited by: Jian Zhang and Chao-Nan Qian

Aims and scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.

Editor-in-Chief

Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Information for authors

Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.

Cancer Communications

Articles

Overexpression of amplified in breast cancer 1 (AIB1) gene promotes lung adenocarcinoma aggressiveness in vitro and in vivo by upregulating C-X-C motif chemokine receptor 4

Tumor vasculature: a sally port for inhibiting cancer cell spreading

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience

Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways

Lower genomic stability of induced pluripotent stem cells reflects increased non-homologous end joining

Predictive biomarkers in precision medicine and drug development against lung cancer

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Cell-free circulating tumor DNA in cancer

2018

2017

2016

2015

Archival content

Important notice

Thematic series

Aims and scope

Editor-in-Chief

Information for authors

Affiliated with

Follow

2017 Journal Metrics

Cancer Communications

Contact us